Login / Signup

18F-FDG-PET/CT in Patients with Advanced, Radioiodine Refractory Thyroid Cancer Treated with Lenvatinib.

Freba AhmaddyCaroline Alexandra BurgardLeonie BeyerViktoria Florentine KoehlerPeter BartensteinMatthias Philipp FabritiusThomas GeyerVera WenterHarun IlhanChristine SpitzwegAndrei Todica
Published in: Cancers (2021)
Tumor response assessment by 18F-FDG-PET outperforms morphological response assessment by CT in patients with advanced radioiodine refractory DTC treated with Lenvatinib, which seems to be correlated with clinical outcomes.
Keyphrases
  • positron emission tomography
  • computed tomography
  • pet ct
  • pet imaging
  • contrast enhanced
  • magnetic resonance imaging
  • image quality
  • magnetic resonance
  • newly diagnosed